An Electronic Health Record–Based Strategy to Enhance Detection of Alpha-1 Antitrypsin Deficiency
Respiratory Care · 2025
DOI: 10.1089/respcare.12200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respiratory Care, 2025. Verfasst von Avantika Nathani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Nathani is affiliated with Integrated Hospital Care Institute, Respiratory, Cleveland Clinic, Cleveland, Ohio. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin Deficiency, Electronic Health Records. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
Because alpha-1 antitrypsin deficiency is severely underrecognized and delayed diagnosis is associated with harm, strategies to enhance early detection of alpha-1 antitrypsin deficiency are needed.
Methods
The study intervention was placing a reminder to test for alpha-1 antitrypsin deficiency within an electronic medical record health maintenance dashboard that houses prompts to providers to implement guideline-based recommendations. This recommendation was for all patients assigned a diagnosis of COPD based on relevant International Classification of Diseases, Tenth Revision codes. The rate of testing for and detecting individuals with alpha-1 antitrypsin deficiency was assessed in 12 one-month intervals before and after implementing the dashboard.
Results
After the prompt, whereas testing was still performed in only a small percentage of guideline-concordant instances, the rate of testing for alpha-1 antitrypsin deficiency increased 3.8-fold (ie, from 1.2% to 4.6%, P < .05). This did not result in detection of new patients with alpha-1 antitrypsin deficiency. The rate of testing increased both for alpha-1 antitrypsin serum levels and genotypes in each month after the intervention, though the rate of genotype testing was 2-5-fold lower than the rate of testing for serum level.
Conclusions
The results of this preliminary study of a detection strategy for alpha-1 antitrypsin deficiency show that placing a reminder to test for alpha-1 antitrypsin deficiency when indicated in an electronic medical record health maintenance dashboard significantly increased the frequency of testing. Still, that only 4.6% of those in whom testing for alpha-1 antitrypsin deficiency was indicated were tested in the post-intervention period shows that, as for all other alpha-1 antitrypsin deficiency-targeted detection interventions to date, the impact of the intervention was marginal and that other strategies remain needed to mitigate underrecognition. A focus on combining targeted detection strategies (eg, coupling enhanced awareness with free testing) and population-based screening for alpha-1 antitrypsin deficiency is suggested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. Nathani is affiliated with Integrated Hospital Care Institute, Respiratory, Cleveland Clinic, Cleveland, Ohio.
- Dr. Stoller is affiliated with Integrated Hospital Care Institute, Respiratory, Cleveland Clinic, Cleveland, Ohio; and Education Institute Cleveland Clinic, Cleveland, Ohio.
Zitieren
APA
Nathani, A., & Stoller, J. K. (2025). An Electronic Health Record–Based Strategy to Enhance Detection of Alpha-1 Antitrypsin Deficiency. Respiratory Care. https://doi.org/10.1089/respcare.12200
Vancouver
Nathani A, Stoller JK. An Electronic Health Record–Based Strategy to Enhance Detection of Alpha-1 Antitrypsin Deficiency. Respiratory Care. 2025. doi:10.1089/respcare.12200
BibTeX
@article{Nathani2025,
author = {Nathani, Avantika and Stoller, James K},
title = {An Electronic Health Record–Based Strategy to Enhance Detection of Alpha-1 Antitrypsin Deficiency},
journal = {Respiratory Care},
year = {2025},
doi = {10.1089/respcare.12200}
}
EUVIMED